Validation study reveals new tool can predict patients' genetic risk of 8 cardiovascular conditions

Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic ...
Seeking Alpha

Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK ...

FRIENDSWOOD, Texas, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a ...
EurekAlert!

Validation study from Mass General Brigham reveals new tool can predict patients’ genetic risk of eight cardiovascular conditions

In their validation study, they showed that individuals with high genetic risk scores had significantly greater odds of developing disease compared to those with average risk.